Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR-ABL1 transcript decline velocity in chronic myeloid leukemia: A 16-year real-world study.

Cancer·2026
Same author

Propensity Score-Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Cytokine receptor and JAK/STAT pathway mutations in acute myeloid leukemia: Prevalence and clinical impact.

Cancer·2026
Same author

Real-World Survival Outcomes and Prognostic Factors in De Novo Stage IV Urothelial Bladder Cancer: A 13-Year Retrospective Cohort Study.

Clinical genitourinary cancer·2026
Same author

The Impact of Immunotherapy on Incidence of Second Primary Malignancies: A Surrogate for Antitumor Surveillance Activation.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study.

Lung cancer (Amsterdam, Netherlands)·2025

Related Experiment Video

Updated: May 19, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Detecting and exploiting etiologic heterogeneity in epidemiologic studies.

Colin B Begg1, Emily C Zabor

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. beggc@mskcc.org

American Journal of Epidemiology
|August 28, 2012
PubMed
Summary

Analyzing disease subtypes can improve the discovery of new genetic risk factors. Subtyping increases statistical power by focusing on etiologic heterogeneity, but requires careful selection of relevant subtypes for optimal results.

Related Experiment Videos

Last Updated: May 19, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Area of Science:

  • Genetics
  • Epidemiology
  • Biostatistics

Background:

  • Genome-wide association studies (GWAS) are common for identifying genetic risk factors.
  • Diseases often have subtypes with different causes (etiologic heterogeneity).
  • The impact of analyzing subtypes separately in genetic risk factor searches is not well understood.

Purpose of the Study:

  • To investigate whether analyzing disease subtypes separately improves the statistical power for detecting new genetic risk factors.
  • To determine the conditions under which subtyping strategies are most effective.
  • To provide guidance on selecting subtypes that exhibit substantial etiologic heterogeneity.

Main Methods:

  • Statistical modeling to assess the power of subtyping strategies.
  • Analysis of simulated data to evaluate the impact of varying degrees of etiologic heterogeneity.
  • Application of the concepts to a real-world breast cancer dataset with estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) subtypes.

Main Results:

  • Even modest etiologic heterogeneity can significantly enhance statistical power when analyzing subtypes separately.
  • The benefits of subtyping are maximized when subtypes with substantial heterogeneity are chosen.
  • False discovery rates must be managed alongside power gains due to smaller sample sizes within subtypes.

Conclusions:

  • Subtyping diseases based on etiologic heterogeneity can improve the efficiency of genetic risk factor discovery.
  • Careful selection of biologically relevant subtypes is crucial for successful implementation.
  • This approach offers a powerful strategy for navigating complex genetic architectures of diseases.